{"id":"W2610814060","doi":"10.1200/jco.2009.27.15_suppl.3584","title":"A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Toxicity; Internal medicine; Clinical endpoint; Pharmacokinetics; Cancer; Pharmacology; Oncology; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001030827,0.001534933,0.001920634,0.0004041354,0.0003604524,0.0009114667,0.0007658894,0.001199273,0.002592209],"category_scores_gemma":[0.0008795115,0.0006692095,0.0009606403,0.0004076159,0.00102764,0.0007602109,0.0004439168,0.002950351,0.000709094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008588564,"about_ca_system_score_gemma":0.001220255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007921117,"about_ca_topic_score_gemma":0.001749615,"domain_scores_codex":[0.9996431,0.0001811161,0.00001858761,0.00006354899,0.00002407619,0.00006956464],"domain_scores_gemma":[0.9994318,0.0001051691,0.00009476462,0.00005548936,0.00002485984,0.0002878954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7096686,0.1237676,0.006364999,0.0008853974,0.0008682631,0.0005930599,0.0005735758,0.004354676,0.06430009,0.0003197336,0.002602218,0.08570188],"study_design_scores_gemma":[0.3356458,0.649888,0.007217359,0.00002419304,0.0002230555,0.0003281162,0.00006228182,0.0009340625,0.003518052,0.0001099097,0.002025222,0.00002390508],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995381,0.0007875665,0.0003966311,0.000228308,0.00006888354,0.00178107,0.0003081642,0.00005039498,0.0009979481],"genre_scores_gemma":[0.9925457,0.0009680245,0.001476977,0.0004326917,0.0001377921,0.001711926,0.0009636806,0.00002109116,0.001742188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002592209,"threshold_uncertainty_score":0.00867182,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0411633948899154,"score_gpt":0.4463708909763021,"score_spread":0.4052074960863867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}